Integrin inhibitor, c(phg-isoDGR-(NMe)k), Purity ≥98%

Synonym: 1844830-65-4; EX-A7488; HY-111413; CS-0040557; (5S,8R,11R,14S)-8-(4-Aminobutyl)-5-[3-(diaminomethylideneamino)propyl]-7-methyl-3,6,9,12,16-pentaoxo-11-phenyl-1,4,7,10,13-pentazacyclohexadecane-14-carboxylic acid

CAS Number: 1844830-65-4
Compound CID: 137628646

Product Size

1 mg; 5 mg; 10 mg; 50 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

c(phg-isoDGR-(NMe)k) is an effective cytoskeleton inhibitor, that has the ability to prevent the pathway of cytoskeletal signaling by inhibiting integrin.

Molecular Weight

603.67

Molecular Formula

C₂₇H₄₁N₉O₇

Form

Lyophilized powder

Purity

≥98%

Titer

Free from inappropriate visible particulates, foreign matter, discoloration, or other defects

Stability

In its lyophilized form, the chemical remains stable for 36 months.

Quality Level

Research grade

Applications

c(phg-isoDGR-(NMe)k) is a cytoskeletal signaling inhibitor that plays a key role in research to study integrin 伪v尾6-mediated cellular processes, particularly in the context of fibrosis and cancer.

Storage

Store at -20ºC, and keep desiccated.